Evidence map›Paper›PMID 39698562›Full record

ReviewTranslational andrology and urology2024

Development of a new Peyronie's disease self-assessment screening app.

Gregory A Broderick, Jesse N Mills, Lisa Bathish, Christopher Davis, Mohit Khera

Abstract readReview
In one paragraph

Review in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gregory A BroderickDepartment of Urology, Mayo Clinic, Jacksonville, FL, USA.
Jesse N MillsDavid Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Lisa BathishResearch and Development, Endo USA, Inc., Malvern, PA, USA.
Christopher DavisResearch and Development, Endo USA, Inc., Malvern, PA, USA.
Mohit KheraScott Department of Urology, Baylor College of Medicine Medical Center, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peyronie's disease (PD) is an underdiagnosed and undertreated fibroproliferative disorder associated with the formation of plaques that results in penile curvature and discourages some men from seeking medical consultation. The PD self-assessment app, a digital application (app), was developed to increase PD awareness, provide men with a self-screening and educational tool for PD, and help eliminate barriers to seeking consultation with a physician. Prior to deployment, 4 board-certified urologists provided qualitative reviews on the app's usability and utility as a screening tool. The PD self-assessment app features a questionnaire that addresses penile curvature, challenges with penetration, partner distress, and the impact on sexual experiences. The app uses the phone's camera lens to perform a live scan employing a mathematical algorithm to determine the degree of curvature of an erect penis. Results include a three-dimensional (3D) penile simulation and a two-dimensional (2D) penile outline, allowing the user to mark plaque locations and determine the maximum curvature without requiring personal photographs. The user can choose to email their answers to the questionnaire and the representative penile simulation results to their physician. The app also includes external links directing users to an educational website focused on PD and to help with finding a treating physician. The app was designed with privacy and security features including optional password protection, encryption of sensitive data, in-app storage of all screening results, and the erasing of all data when the app is uninstalled. Patients will be empowered to self-assess their PD and locate a PD-experienced physician privately and securely. The app is not designed for diagnosing, treating, curing, or preventing any medical conditions, or diseases, nor does it substitute for a medical consultation. For security, scanning technology, rather than personal photography, is adjunctive to the diagnosis process. The app is designed to be flexible and expandable for future updates. It aims to assist men and their partners in learning about PD, tracking penile deformity, and enabling communication with a health care provider (HCP).

Indexed as

mobile applicationsPenile curvaturePeyronie’s disease (PD)Peyronie’s plaqueself-assessment

Identifiers

PMID39698562
PMCPMC11650355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.